We are live on
!
Find out more
LVTX
LAVA Therapeutics
LVTX
LVTX
Delisted
LVTX was delisted on the 20th of November, 2025.
20 hedge funds and large institutions have $12.5M invested in LAVA Therapeutics in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
43% more funds holding
Funds holding: 14 → 20 (+6)
35% more capital invested
Capital invested by funds: $9.26M → $12.5M (+$3.26M)
7.99% less ownership
Funds ownership: 22.29% → 14.31% (-8%)
50% less call options, than puts
Call options by funds: $102K | Put options by funds: $203K
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
20
Holders Change
+6
Holders Change %
+42.86%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
1
Reduced
2
Closed
5
Calls
$102K
Puts
$203K
Net Calls
-$101K
Net Calls Change
-$135K
Top Buyers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$809K |
| 2 |
Walleye Capital
New York
|
+$340K |
| 3 |
Two Sigma Investments
New York
|
+$181K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$40.3K |
| 5 |
Two Sigma Advisers
New York
|
+$36.7K |
Top Sellers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$2.97M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.33M |
| 3 |
Morgan Stanley
New York
|
-$86.7K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$47.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$18.1K |
